[A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease].
D000203:Activities of Daily Living / Q000523:psychology; D001577:Benzophenones / Q000627:therapeutic use; D052160:Benzothiazoles; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D009596:Nitrophenols; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology; D010479:Pergolide / Q000627:therapeutic use; D000077487:Pramipexole; D011788:Quality of Life; D013844:Thiazoles / Q000627:therapeutic use; D000077867:Tolcapone; D016896:Treatment Outcome
D001577:Benzophenones; D052160:Benzothiazoles; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols; D018491:Dopamine Agonists; D004791:Enzyme Inhibitors; D009570:Nitriles; D009596:Nitrophenols; D013844:Thiazoles; D010479:Pergolide; C071192:entacapone; D000077487:Pramipexole; D000077867:Tolcapone
Sravnitel'noe issledovanie éffektivnosti agonistov dofaminovykh retseptorov i ingibitorov katekhol-O-metiltransferazy v lechenii pozdnikh stadiĭ bolezni Parkinsona.